Fair objections

The Vitamin A Question On An Eye Supplement Label

Vitamin A earns its place in an eye formula honestly: bound to a protein in the photoreceptors it becomes the molecule that responds to light. It is also the ingredient AREDS2 took out, and the reason it did so decides whether a particular person should take a particular bottle.

Written by Visivra Team at Myvisivra · Reviewed by Dr. Rishi Singh, MD · Updated November 4, 2026 · Fair objections

Why vitamin A is on eye labels at all

The case for vitamin A in an eye formula is the oldest and most solid in the whole category, and it is worth stating before anything critical.

A photoreceptor works by breaking a molecule. Light strikes rhodopsin, which is a vitamin A derivative bound to a protein, and changes its shape; that change is the signal the brain eventually reads. The molecule then has to be rebuilt, and the raw material for rebuilding it is vitamin A.

Severe vitamin A deficiency causes night blindness and, if it continues, permanent damage. It remains a major cause of preventable childhood blindness in parts of the world. MedlinePlus sets out the vitamin's roles and its sources.

Why that does not settle the question

Correcting a deficiency and supplementing someone who is not deficient are different interventions with different risk profiles. Almost nobody in a developed country buying an eye supplement is vitamin A deficient, which means the relevant literature is not the deficiency literature at all.

One name, two molecules

This is the distinction the whole article turns on, and most labels do not make it.

One name on a label, two molecules, two different research histories. This is the reason the form is the first question to ask.

A row reading Vitamin A with a microgram figure beside it is usually preformed. A row reading beta carotene is provitamin. A row reading Vitamin A with no figure and no form is an unanswered question, and which answer applies changes who should take the product.

What happened with beta carotene

Two large trials in the 1990s set out to test whether beta carotene supplementation reduced cancer risk. Both found the opposite in the group they were most interested in.

Three trials, one direction of effect, and one population in which it appears. The third is why AREDS2 rebuilt its own formula.

The doses in the first row of that table are worth reading twice. CARET combined beta carotene 30 mg with retinol 25,000 IU daily, in people whose baseline lung cancer risk was already raised, and the trial ended before its planned finish because the supplemented arm was faring worse.

ATBC gave beta carotene 20 mg a day to male smokers, alongside alpha-tocopherol, and found the same direction of effect. Two independent trials, two populations of smokers, one uncomfortable answer.

It is important to be accurate about the limit of that finding. The signal is in smokers and former smokers at high supplemental amounts. Beta carotene from food has no such record, and nobody is suggesting carrots are a hazard.

The preformed vitamin A literature

Preformed vitamin A has a different concern attached to it, and it is about bone rather than lung.

A Swedish cohort study related serum retinol levels to fracture risk, and the Iowa Women's Health Study examined vitamin A intake and hip fracture in postmenopausal women. Neither is a randomised trial and both are worth reading rather than summarising into a slogan.

The ceiling for the preformed form is 3,000 micrograms RAE a day in adults, set in the Institute of Medicine chapter. It applies to retinol and its esters rather than to beta carotene, and it counts everything at once: a multivitamin, a liver-heavy diet, a retinoid medicine and an eye supplement all contribute to the same total.

Why AREDS2 rebuilt its own formula

The original AREDS formula carried beta carotene 15 mg. By the time AREDS2 was designed, CARET and ATBC had both reported, and running a large trial of a formula containing beta carotene in a population that included former smokers had become difficult to justify.

So AREDS2 tested removing it, and the ten-year follow-up reported the numbers: 23 lung cancers in the beta carotene arm against 11 in the arm without it, mostly in former smokers, odds ratio 1.82 (95% CI 1.06–3.12; P=.02).

The modern AREDS2 formula therefore carries no beta carotene at all. Lutein and zeaxanthin took its place, which is how the two carotenoids came to dominate this category in the first place.

The irony worth noticing

A great many eye supplements now quote AREDS2 on the label and carry a vitamin A row that AREDS2 removed. That is not necessarily wrong: a small amount of preformed vitamin A is a different proposition from 15 mg of beta carotene. But a label that quotes the trial and reinstates the ingredient owes its reader the form, at minimum.

The check to run on any label

This is the most portable thing in this article and it takes five seconds.

1. Find the vitamin A row. If there is not one, the check is over and the product has taken the AREDS2 position.
2. Read what it says. Beta carotene, retinol, retinyl palmitate, or just Vitamin A.
3. If it names a form and an amount, the product can be assessed. Compare the amount against 3,000 micrograms RAE for preformed.
4. If it names neither, the product cannot be assessed from its label, and the seller is the only route to the answer.
5. If you smoke or used to, treat step four as a stop rather than a shrug. This is the one group for whom the answer decides the purchase.

• A product with no vitamin A row at all is taking the position AREDS2 arrived at, and that is a defensible choice rather than an omission.
• A product naming beta carotene and an amount is making a choice a smoker should know about.
• A product naming preformed vitamin A and an amount can be added to whatever else is in the cabinet and checked against a ceiling.
• A product naming neither has left the most consequential row on its label to a telephone call.

What this applies to on the product sold here

This website sells an eye supplement whose label names Vitamin A and gives neither the form nor the amount. That is the fourth case in the list above, and it is stated here rather than left for a reader to notice.

The practical consequence is a telephone call to the order desk, before the first bottle rather than after it, asking which form the capsule uses. For a smoker or an ex-smoker that answer is not a detail: it is the thing the whole purchase turns on.

The full account sits on the side effects page, the check appears as row four of the eight-point scorecard on the choosing guide, where this product fails it, and the ingredients page prints what the trials used beside what the label says.

References